{"id":"https://openalex.org/W1920293046","doi":"https://doi.org/10.1111/bcp.12715","title":"Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery","display_name":"Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery","publication_year":2015,"publication_date":"2015-07-03","ids":{"openalex":"https://openalex.org/W1920293046","doi":"https://doi.org/10.1111/bcp.12715","mag":"1920293046","pmid":"https://pubmed.ncbi.nlm.nih.gov/26138622","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4631187"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.12715","doi":"https://doi.org/10.1111/bcp.12715","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12715","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4631187","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010749476","display_name":"Graham A. Powell","orcid":"https://orcid.org/0000-0003-3840-2534","observed_orcids":["https://orcid.org/0000-0003-3840-2534"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham Powell","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026611931","display_name":"Emily A. F. Holmes","orcid":"https://orcid.org/0000-0002-0479-5336","observed_orcids":["https://orcid.org/0000-0002-0479-5336"]},"institutions":[{"id":"https://openalex.org/I161548249","display_name":"Bangor University","ror":"https://ror.org/006jb1a24","country_code":"GB","type":"education","lineage":["https://openalex.org/I161548249"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Emily A. F. Holmes","raw_affiliation_strings":["Centre for Health Economics and Medicines Evaluation Bangor University Bangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics and Medicines Evaluation Bangor University Bangor","institution_ids":["https://openalex.org/I161548249"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001722721","display_name":"Catrin Plumpton","orcid":"https://orcid.org/0000-0003-2710-9199","observed_orcids":["https://orcid.org/0000-0003-2710-9199"]},"institutions":[{"id":"https://openalex.org/I161548249","display_name":"Bangor University","ror":"https://ror.org/006jb1a24","country_code":"GB","type":"education","lineage":["https://openalex.org/I161548249"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Catrin O. Plumpton","raw_affiliation_strings":["Centre for Health Economics and Medicines Evaluation Bangor University Bangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics and Medicines Evaluation Bangor University Bangor","institution_ids":["https://openalex.org/I161548249"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109131139","display_name":"Adele Ring","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adele Ring","raw_affiliation_strings":["Department of Public Health and Policy, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Policy, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038003929","display_name":"Gus A. Baker","orcid":"https://orcid.org/0000-0002-5736-605X","observed_orcids":["https://orcid.org/0000-0002-5736-605X"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gus A. Baker","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108081742","display_name":"Ann Jacoby","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ann Jacoby","raw_affiliation_strings":["Department of Public Health and Policy, University of Liverpool, Liverpool, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Public Health and Policy, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006847944","display_name":"Munir Pirmohamed","orcid":"https://orcid.org/0000-0002-7534-7266","observed_orcids":["https://orcid.org/0000-0002-7534-7266"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Munir Pirmohamed","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005069325","display_name":"Anthony Guy Marson","orcid":"https://orcid.org/0000-0002-6861-8806","observed_orcids":["https://orcid.org/0000-0002-6861-8806"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Anthony G. Marson","raw_affiliation_strings":["Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070376982","display_name":"Dyfrig Arwyn Hughes","orcid":"https://orcid.org/0000-0001-8247-7459","observed_orcids":["https://orcid.org/0000-0001-8247-7459"]},"institutions":[{"id":"https://openalex.org/I161548249","display_name":"Bangor University","ror":"https://ror.org/006jb1a24","country_code":"GB","type":"education","lineage":["https://openalex.org/I161548249"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Dyfrig A. Hughes","raw_affiliation_strings":["Centre for Health Economics and Medicines Evaluation Bangor University Bangor"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Health Economics and Medicines Evaluation Bangor University Bangor","institution_ids":["https://openalex.org/I161548249"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5070376982"],"corresponding_institution_ids":["https://openalex.org/I161548249"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":2.2039,"has_fulltext":false,"cited_by_count":38,"citation_normalized_percentile":{"value":0.85435564,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"80","issue":"5","first_page":"1149","last_page":"1159"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.7143999934196472,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.7143999934196472,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.16609999537467957,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.0608999989926815,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenetic-testing","display_name":"pharmacogenetic testing","score":0.9639999866485596},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/hla-a-31-01","display_name":"HLA-A*31:01","score":0.9890000224113464},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.9860000014305115},{"id":"https://openalex.org/keywords/patient-preferences","display_name":"patient preferences","score":0.9369999766349792},{"id":"https://openalex.org/keywords/physician-preferences","display_name":"physician preferences","score":0.9419999718666077},{"id":"https://openalex.org/keywords/willingness-to-pay","display_name":"willingness to pay","score":0.7979999780654907},{"id":"https://openalex.org/keywords/predictive-value","display_name":"predictive value","score":0.7979999780654907},{"id":"https://openalex.org/keywords/discrete-choice-experiment","display_name":"discrete choice experiment","score":0.734000027179718},{"id":"https://openalex.org/keywords/service-delivery","display_name":"service delivery","score":0.5379999876022339}],"concepts":[{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.8361549377441406},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.747260570526123},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7242966294288635},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6271855235099792},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.6231945753097534},{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.537421703338623},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4956890344619751},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.47567620873451233},{"id":"https://openalex.org/C100406419","wikidata":"https://www.wikidata.org/wiki/Q3543802","display_name":"Formulary","level":2,"score":0.47026926279067993},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33581334352493286},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3324401378631592},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3232395052909851},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.27910318970680237},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001291","descriptor_name":"Attitude of Health Personnel","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005820","descriptor_name":"Genetic Testing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010597","descriptor_name":"Pharmacogenetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010820","descriptor_name":"Physicians","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057240","descriptor_name":"Patient Preference","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1111/bcp.12715","doi":"https://doi.org/10.1111/bcp.12715","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.12715","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4034123","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4631187","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4631187","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4631187","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:26138622","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26138622","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:e.bangor.ac.uk:4704","doi":null,"is_oa":false,"landing_page_url":"http://e.bangor.ac.uk/4704/1/32275.pdf","pdf_url":"http://e.bangor.ac.uk/4704/1/32275.pdf","source":{"id":"https://openalex.org/S4306402103","display_name":"Bangor University Research Portal (Bangor University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I161548249","host_organization_name":"Bangor University","host_organization_lineage":["https://openalex.org/I161548249"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Article"},{"id":"pmh:oai:research.bangor.ac.uk:publications/9683abae-4abb-497d-bfeb-743d658154ff","doi":null,"is_oa":true,"landing_page_url":"https://research.bangor.ac.uk/portal/en/researchoutputs/pharmacogenetic-testing-prior-to-carbamazepine-treatment-of-epilepsy-1-patients-and-physicians-preferences-for-testing-and-service-delivery(9683abae-4abb-497d-bfeb-743d658154ff).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402103","display_name":"Bangor University Research Portal (Bangor University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I161548249","host_organization_name":"Bangor University","host_organization_lineage":["https://openalex.org/I161548249"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Powell , G , Holmes , E A , Plumpton , C O , Ring , A , Baker , G A , Jacoby , A , Pirmohamed , M , Marson , A G & Hughes , D A 2015 , ' Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: 1 patients\u2019 and physicians\u2019 preferences for testing and service delivery ' , British Journal of Clinical Pharmacology , vol. 80 , no. 5 , pp. 1149-1159 . https://doi.org/10.1111/bcp.12715","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:4034123","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4631187","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G105075340","display_name":null,"funder_award_id":"ACF-2011-07-004","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G2100064677","display_name":"Centre for Drug Safety Science (CDSS)","funder_award_id":"MR/L006758/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G2608274386","display_name":"Defining patient preferences and priorities for treatment options and outcomes in epilepsy","funder_award_id":"PB-PG-0909-20161","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G2732435371","display_name":"NIHR Senior Investigator Award","funder_award_id":"NF-SI-0512-10064","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G3309629460","display_name":null,"funder_award_id":"G0800792","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":22,"referenced_works":["https://openalex.org/W1487038602","https://openalex.org/W1562592376","https://openalex.org/W1602006543","https://openalex.org/W1964212813","https://openalex.org/W1966242613","https://openalex.org/W1968550669","https://openalex.org/W1973459480","https://openalex.org/W1983256621","https://openalex.org/W2036264839","https://openalex.org/W2044645437","https://openalex.org/W2049902892","https://openalex.org/W2051267089","https://openalex.org/W2058748891","https://openalex.org/W2062517087","https://openalex.org/W2108686931","https://openalex.org/W2116243022","https://openalex.org/W2121722424","https://openalex.org/W2138521331","https://openalex.org/W2139992285","https://openalex.org/W2156585872","https://openalex.org/W2166610199","https://openalex.org/W2170468317"],"related_works":["https://openalex.org/W2024257655","https://openalex.org/W1973459480","https://openalex.org/W1898304137","https://openalex.org/W4416398006","https://openalex.org/W1151969024","https://openalex.org/W2586009928","https://openalex.org/W2345597565","https://openalex.org/W7154913357","https://openalex.org/W4392299124","https://openalex.org/W3212549485"],"abstract_inverted_index":{"AIM:":[0],"Pharmacogenetic":[1],"studies":[2],"have":[3],"identified":[4,50,213],"the":[5,8,27,79,82,90,134,140,200,239],"presence":[6],"of":[7,14,29,41,81,86,114,158,189,202,223,233,241],"HLA-A*31:01":[9,242],"allele":[10],"as":[11],"a":[12,169,179,224,230],"predictor":[13],"cutaneous":[15],"adverse":[16],"drugs":[17],"reactions":[18],"(ADRs)":[19],"to":[20,25,33,43,77,165,199,208],"carbamazepine.":[21,210],"This":[22],"study":[23],"aimed":[24],"ascertain":[26],"preferences":[28,203],"patients":[30],"and":[31,47,53,68,84,105,149,176,192],"clinicians":[32],"inform":[34],"carbamazepine":[35],"pharmacogenetic":[36,205],"testing":[37,115,126,206,243],"services.":[38],"METHODS:":[39],"Attributes":[40],"importance":[42,80],"people":[44,65],"with":[45,66],"epilepsy":[46,67],"neurologists":[48,162],"were":[49,61,75,109,154,163],"through":[51],"interviews":[52],"from":[54],"published":[55],"sources.":[56],"Discrete":[57],"choice":[58],"experiments":[59],"(DCEs)":[60],"conducted":[62],"in":[63,98,139,174,184,226,244],"82":[64],"83":[69],"neurologists.":[70],"Random-effects":[71],"logit":[72],"regression":[73],"models":[74],"used":[76],"determine":[78],"attributes":[83,94,215],"direction":[85],"effect.":[87],"RESULTS:":[88],"In":[89,133],"patient":[91],"DCE,":[92,136],"all":[93],"(seizure":[95],"remission,":[96],"reduction":[97],"seizure":[99],"frequency,":[100],"memory":[101],"problems,":[102],"skin":[103],"rash":[104],"rare,":[106],"severe":[107,234],"ADRs)":[108],"significant.":[110,155],"The":[111,187],"estimated":[112],"utility":[113],"was":[116],"greater,":[117],"at":[118,127],"0.52":[119],"(95%":[120,129],"CI":[121,130],"0.19,":[122],"1.00)":[123],"than":[124],"not":[125],"0.33":[128],"-0.07,":[131],"0.81).":[132],"physician":[135],"cost,":[137],"inclusion":[138,188],"British":[141],"National":[142],"Formulary,":[143],"coverage,":[144],"negative":[145],"predictive":[146,151],"value":[147,152],"(NPV)":[148],"positive":[150],"(PPV)":[153],"Marginal":[156],"rates":[157],"substitution":[159],"indicated":[160],"that":[161],"willing":[164],"pay":[166],"\u00a35.87":[167],"for":[168,178,229,238],"1":[170,180],"percentage":[171,181],"point":[172,182],"increase":[173,183],"NPV":[175],"\u00a33.99":[177],"PPV.":[185],"CONCLUSION:":[186],"both":[190],"patients'":[191],"clinicians'":[193],"perspectives":[194],"represents":[195],"an":[196],"important":[197],"contribution":[198],"understanding":[201],"towards":[204],"prior":[207],"initiating":[209],"Both":[211],"groups":[212],"different":[214],"but":[216],"had":[217],"generally":[218],"consistent":[219],"preferences.":[220],"Patients'":[221],"acceptance":[222],"decrease":[225],"treatment":[227],"benefit":[228],"reduced":[231],"chance":[232],"ADRs":[235],"adds":[236],"support":[237],"implementation":[240],"routine":[245],"practice.":[246]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}